Literature DB >> 34520670

Potential role of functional imaging in predicting outcome for patients treated with carbon ion therapy: a review.

Giulia Riva1, Sara Imparato1, Giovanni Savietto2, Mattia Pecorilla1, Alberto Iannalfi1, Amelia Barcellini1, Sara Ronchi1, Maria Rosaria Fiore1, Chiara Paganelli3, Giulia Buizza3, Mario Ciocca1, Guido Baroni3, Lorenzo Preda2,4, Ester Orlandi1.   

Abstract

OBJECTIVE: Carbon ion radiation therapy (CIRT) is an emerging radiation technique with advantageous physical and radiobiologic properties compared to conventional radiotherapy (RT) providing better response in case of radioresistant and hypoxic tumors. Our aim is to critically review if functional imaging techniques could play a role in predicting outcome of CIRT-treated tumors, as already proven for conventional RT.
METHODS: 14 studies, concerning Magnetic resonance imaging (MRI) and Positron Emission Tomography (PET), were selected after a comprehensive search on multiple electronic databases from January 2000 to March 2020.
RESULTS: MRI studies (n = 5) focused on diffusion-weighted MRI and, even though quantitative parameters were the same in all studies (apparent diffusion coefficient, ADC), results were not univocal, probably due to different imaging acquisition protocols and tumoral histology. For PET studies (n = 9), different tracers were used such as [18F]FDG and other uncommon tracers ([11C]MET, [18F]FLT), with a relevant heterogeneity regarding parameters used for outcome assessment.
CONCLUSION: No conclusion can be drawn on the predictive value of functional imaging in CIRT-treated tumors. A standardization of image acquisition, multi-institutional large trials and external validations are needed in order to establish the prognostic value of functional imaging in CIRT and to guide clinical practice. ADVANCES IN KNOWLEDGE: Emerging studies focused on functional imaging's role in predicting CIRT outcome. Due to the heterogeneity of images acquisition and studies, results are conflicting and prospective large studies with imaging standardized protocol are needed.

Entities:  

Mesh:

Year:  2021        PMID: 34520670      PMCID: PMC8631012          DOI: 10.1259/bjr.20210524

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  63 in total

1.  Standard uptake value and metabolic tumor volume of ¹⁸F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer.

Authors:  Wei Huang; Tao Zhou; Li Ma; Hongfu Sun; Heyi Gong; Juan Wang; Jinming Yu; Baosheng Li
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-27       Impact factor: 9.236

Review 2.  Radiation oncology in the era of precision medicine.

Authors:  Michael Baumann; Mechthild Krause; Jens Overgaard; Jürgen Debus; Søren M Bentzen; Juliane Daartz; Christian Richter; Daniel Zips; Thomas Bortfeld
Journal:  Nat Rev Cancer       Date:  2016-03-18       Impact factor: 60.716

3.  Carbon Ion Radiation Therapy for Unresectable Sacral Chordoma: An Analysis of 188 Cases.

Authors:  Reiko Imai; Tadashi Kamada; Nobuhito Araki
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-02-08       Impact factor: 7.038

4.  Maximum standardized uptake value on FDG-PET predicts survival in stage I non-small cell lung cancer following carbon ion radiotherapy.

Authors:  Katsuyuki Shirai; Takanori Abe; Jun-Ichi Saitoh; Tatsuji Mizukami; Daisuke Irie; Yosuke Takakusagi; Shintaro Shiba; Naoko Okano; Takeshi Ebara; Tatsuya Ohno; Takashi Nakano
Journal:  Oncol Lett       Date:  2017-03-29       Impact factor: 2.967

Review 5.  Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy.

Authors:  Sonja Stieb; Afroditi Eleftheriou; Geoffrey Warnock; Matthias Guckenberger; Oliver Riesterer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-20       Impact factor: 9.236

6.  Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck.

Authors:  Sungheon Kim; Laurie Loevner; Harry Quon; Eric Sherman; Gregory Weinstein; Alex Kilger; Harish Poptani
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

7.  3'-Deoxy-3'-18F-fluorothymidine PET-derived proliferative volume predicts overall survival in high-grade glioma patients.

Authors:  Albert J S Idema; Aswin L Hoffmann; Hieronymus D Boogaarts; Esther G C Troost; Pieter Wesseling; Arend Heerschap; Winette T A van der Graaf; J Andre Grotenhuis; Wim J G Oyen
Journal:  J Nucl Med       Date:  2012-10-17       Impact factor: 10.057

Review 8.  Radiomics in radiation oncology-basics, methods, and limitations.

Authors:  Philipp Lohmann; Khaled Bousabarah; Mauritius Hoevels; Harald Treuer
Journal:  Strahlenther Onkol       Date:  2020-07-09       Impact factor: 3.621

Review 9.  What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis.

Authors:  Pierluigi Bonomo; A Merlotti; E Olmetto; A Bianchi; I Desideri; A Bacigalupo; P Franco; C Franzese; E Orlandi; L Livi; S Caini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-06-09       Impact factor: 9.236

Review 10.  Quantitative imaging for radiotherapy purposes.

Authors:  Oliver J Gurney-Champion; Faisal Mahmood; Marcel van Schie; Robert Julian; Ben George; Marielle E P Philippens; Uulke A van der Heide; Daniela Thorwarth; Kathrine R Redalen
Journal:  Radiother Oncol       Date:  2020-02-27       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.